Insigneo Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$755K Sell
9,650
-1,541
-14% -$124K 0.03% 369
2026
Q1
$970K Sell
11,191
-200
-2% -$19.2K 0.07% 224
2025
Q4
$1.09M Buy
11,391
+547
+5% +$53.1K 0.08% 197
2025
Q3
$1.03M Buy
10,844
+3,059
+39% +$281K 0.07% 210
2025
Q2
$679K Buy
7,785
+581
+8% +$49.3K 0.06% 258
2025
Q1
$647K Buy
7,204
+17
+0.2% +$1.52K 0.07% 241
2024
Q4
$574K Sell
7,187
-2,113
-23% -$183K 0.06% 266
2024
Q3
$837K Sell
9,300
-2,239
-19% -$188K 0.08% 199
2024
Q2
$927K Sell
11,539
-5,433
-32% -$445K 0.1% 183
2024
Q1
$1.49M Buy
+16,972
New +$1.45M 0.18% 113

Other funds holding MDT

Insigneo Advisory Services's MDT Position: Q2 2026 in Review

Insigneo Advisory Services reduced its Medtronic (MDT) stake by 14% in Q2 2026, selling an estimated $124K and leaving 9,650 shares worth $755K. The position accounts for 0.03% of the portfolio, ranked #369.

Insigneo Advisory Services first reported a position in MDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.49M in Q1 2024. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Insigneo Advisory Services held 9,650 shares of Medtronic worth $755K as of Q2 2026.
  • Insigneo Advisory Services sold 1,541 Medtronic shares in Q2 2026, an estimated $124K.
  • Medtronic made up 0.03% of Insigneo Advisory Services's portfolio in Q2 2026, its #369 holding.
  • Insigneo Advisory Services first reported a position in Medtronic in Q1 2024 and has held it in 10 quarters since.
  • Insigneo Advisory Services's Medtronic position peaked at $1.49M in Q1 2024.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Insigneo Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.